微量营养素缺乏及其对儿科息护理住院时间的影响:回顾性队列研究
Doğukan Mustafa Keskin1, Ayhan Çeri1
1Department of Pediatrics, Dr. Ali Kemal Belviranlı Obstetrics and Gynecology Hospital, Konya, Türkiye.
Turkish archives of pediatrics
|November 19, 2025
概括
微量营养素缺乏,特别是维生素D缺乏,在儿科息护理患者中很常见,并且与更长的住院时间有关. 肠道营养支持也预测了长时间住院治疗.
科学领域:
- 儿科缓和护理 儿科缓和护理
- 临床营养学 临床营养学
- 微量营养素的新陈代谢
背景情况:
- 儿科息护理 (PPC) 患者经常面临复杂的健康挑战.
- 微量营养素缺乏会影响患者的治疗结果和住院时间.
- 了解这些缺陷对于优化PPC护理至关重要.
研究的目的:
- 为了确定住院PPC患者中微量营养素缺乏症的患病率.
- 调查这些缺陷与住院时间的长度之间的关系.
主要方法:
- 一个PPC单位81名儿童的回顾性分析.
- 评估了费里丁,维生素D,维生素B12和叶酸的血清水平.
- 基于短期 (≤5天) 与长期 (>5天) 住院的临床和实验室数据的比较,使用后勤回归.
主要成果:
- 45.68%的患者至少有一种微量营养素缺乏.
- 长时间住院与较高的费里和较低的维生素D水平相关.
- 肠道营养支持 (OR: 4.931) 和较低的维生素D水平 (OR: 0.937) 预测了更长的住院时间.
结论:
- 较低的维生素D水平和需要肠道营养支持的需求是PPC中长时间住院的重要预测因素.
- 常规的微量营养素查和有针对性的干预措施可以改善患者的治疗结果.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
232
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Pharmacokinetics in Pediatric Patients: Drug Distribution
247
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247
Pharmacokinetics in Pediatric Patients: Drug Metabolism
179
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
702
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
702
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
620
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
620

